Factor VII antibody [N3C3]
GTX101238
Overview
- SupplierGeneTex
- Product NameFactor VII antibody [N3C3]
- Delivery Days Customer9
- Antibody SpecificityUpon activation of the factor VII, proteolytic cleavage of the peptide bond between Arg(152) and Ile(153) converts Factor VII (FVII) to an activated two-chain form (FVIIa). A heavy chain containing a catalytic domain and a light chain containing 2 EGF-lik
- Application Supplier NoteWB: 1:500-1:3000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsWestern Blot
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration2.32 mg/ml
- ConjugateUnconjugated
- Gene ID2155
- Target nameF7
- Target descriptioncoagulation factor VII
- Target synonymscoagulation factor VII; coagulation factor VII (serum prothrombin conversion accelerator); eptacog alfa; FVII coagulation protein; proconvertin; SPCA
- HostRabbit
- IsotypeIgG
- Protein IDP08709
- Protein NameCoagulation factor VII
- Scientific DescriptionThis gene encodes coagulation factor VII which is a vitamin K-dependent factor essential for hemostasis. This factor circulates in the blood in a zymogen form, and is converted to an active form by either factor IXa, factor Xa, factor XIIa, or thrombin by minor proteolysis. Upon activation of the factor VII, a heavy chain containing a catalytic domain and a light chain containing 2 EGF-like domains are generated, and two chains are held together by a disulfide bond. In the presence of factor III and calcium ions, the activated factor then further activates the coagulation cascade by converting factor IX to factor IXa and/or factor X to factor Xa. Alternative splicing of this gene results in 2 transcripts. Defects in this gene can cause coagulopathy. [provided by RefSeq]
- ReactivityHuman, Mouse
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Anticoagulants inhibit proteolytic clearance of plasma amyloid beta. Yang L et al., 2018 Jan 19, OncotargetRead more